Homeyar Dinshaw is a Cardiology physician. OpenAlex indexes 21 publications with 348 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2005 Veterans Memorial Blvd
Metairie, LA 700026320
Telephone
504-836-9820Registry record last updated 8 Jul 2007.
Industry payments
12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Edwards Lifesciences CorporationProgram year20258 payments
- Amgen Inc.Program year20251 payment
- Abbott LaboratoriesProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
81.2%Statin20.8%Atorvastatin Calcium51%Rosuvastatin Calcium44%Pravastatin Sodium3%Simvastatin2%Part D<11 patientsBeta blocker13.9%Metoprolol Succinate59%Metoprolol Tartrate19%Carvedilol16%Atenolol3%Bisoprolol Fumarate2%Part D<11 patients+ 23 more classes in this area
Blood & clotting
13.9%Factor Xa inhibitor9.3%Eliquis70%Xarelto30%Part D≥76 patientsP2Y12 inhibitor3.4%Clopidogrel91%Brilinta9%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
4.9%Potassium supplement3.4%Potassium Chloride100%Part D≥54 patientsSGLT2 inhibitor1.6%Jardiance100%Part D≥21 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- USE OF WATCHMAN FOR CLOSURE OF A PERI-DEVICE LEAK AFTER INITIAL WATCHMAN IMPLANT
Journal of the American College of Cardiology
2023 - Watchman FLX Implantation for Challenging Left Atrial Appendage Anatomy: Case-Based Discussion
Current Problems in Cardiology
2022 - Impact of cardiorespiratory fitness on outcomes in cardiac rehabilitation
Progress in Cardiovascular Diseases
2021 - Echocardiographic Assessment of Degenerative Mitral Stenosis: A Diagnostic Challenge of an Emerging Cardiac Disease
Current Problems in Cardiology
2017
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”